ABSITE Flashcards

(76 cards)

1
Q

TEG: R

A

Greater 10 min
FFP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

TEG: K

A

Greater 3 min
Cryo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

TEG: α Angle

A

Less 53
Cryo & Plt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

TEG: MA

A

Less 50 mm
Plts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

TEG: LY30

A

Greater 3%
TXA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

BIRADS 0

A

Incomplete
Repeat Mammo or U/S

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

BIRADS1

A

Negative
Routine screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

BIRADS 2

A

Benign
Routine Screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BIRADS 3

A

Probably Benign
6 Month follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

BIRADS 4

A

Suspicious
Tissue Diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BIRADS 5

A

High likelihood of malignancy
Tissue diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BIRADS 6

A

Biopsy proven malignancy
Excision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bethesda I

A

Nondiagnostic
Repeat FNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bethesda II

A

Benign
Clinical or U/S follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Bethesda III

A

AUS/FLUS
Repeat FNA
Lobectomy/Molecular testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bethesda IV

A

Follicular Neoplasm (FN)/SFN
Molecular testing/Lobectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Bethesda V

A

Suspicious for Malignancy
Total/Lobectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Bethesda VI

A

Biopsy proven malignancy
Total/Lobectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Male Breast Cancer

A

MRM
Aromatase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Inflammatory Breast Cancer

A

Neoadjuvant CT -> MRM -> ALND -> Adjuvant XRT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Paget Breast

A

MRM, Nipple-Areolar Complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Invasive ductal carcinoma borders

A

No ink on tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

DCIS Borders

A

2 mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Her2neu (+)

A

Neoadjuvant (Traszumemab) + BCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
DCIS Treatment (Female vs Male)
Female: BCT + Endocrine + Radiation Sentinel lymph node is not recommended for DCIS unless the following apply: lesion>4 cm, palpable mass, mastectomy, and microinvasion. Male: Mastectomy
26
Li Fraumeni
p53 Leukemia Sarcoma Adenocarcinoma Breast
27
PCI Scoring
T1 is a PCI score 1-10, T2 is a PCI score 11-20 T3 is a PCI score 21-30 T4 is a PCI score 31-39 LS0: No tumor; LS1: Tumor up to 0.5 cm; LS2: Tumor b/w 0.5 - 5.0 cm; LS3: Tumor >5 cm or confluent tumor
28
When primary Esophagus can be repaired primary in TEF
Gap is <2 vertebral bones
29
Compartment syndrome
12 mm Hg (Increase pressure) 20 mm Hg (Organ failure)
30
High risk IPMN
1. jaundice 2. enhancing solid component 3. MD >1 cm
31
Worrisome IPMN
1. Size >3 cm 2. Thickened enhancing cyst walls 3. MD 5 - 9 mm 4. Nonenhancing mural nodules 5. Abrupt caliber change 6. Lymphadenopathy 7. Pancreatitis
32
Contraindication to total or head pancreatic resection
Splenic or portal vein thrombosis (Casuses significant operative bleeding due to recanalization)
33
Long term Blind loop sydrome
Due to B2 Medium chain Triglycerides + B12
34
Muir-Torre syndrome
* GI * GU * Breast (MLH1, MSH2)
35
Cowden syndrome
* Mucocutaneous * Endometrial * Thyroid * Breast (PTEN)
36
Gastrectomy margins
Proximal 6 cm Distal 2 cm
37
Triple negative Breast CA
Lumpectomy + Adjuvant XT + Radiation
38
Time span anal nodule needs to be present before biopsy
6 Months
39
Papillary Thyroid Ca Stage III or IV
Age >55 yrs
40
Size of thyroide nodule not needing FNA
<1 c m(10 mm)
41
Desmoplastic melanoma
Resection + Adjuvant radiation
42
Lidocaine dosing
w/ Epi 7 mg/Kg w/o Epi 5 mg/Kg
43
Bupivicaine Dosing
2.5 mg/kg
44
Pancreatitis Surgery: Head
1. Frey 2. Berger 3. Whipple
45
Pancreatitis Surgery: Enlarged duct
Peustow
46
Side Effect: Etomidate
Adrenal Supression
47
Hoffman Elimination Nondepolarizing agents
Atracurium Cisatracurium (Hoffman elimination)
48
Baitracin
Partial thickness burns Nephrotoxic
49
Mupirocin
MRSA
50
Silvadene (Sulfadiazie)
Does not penetrate eschar Prophylaxis Neutropenia
51
Mafenide acetate
Fullthickness burns Penetrates eschar Metaboli aidosis (carbonic anhydrase inhibotor)
52
Silver nitrate
Hyponatremia
53
Contraindication to lumpectomy
1. prior irradiation 2. pos margins 3. inflammatory 4. pregnancy (unless 3rd trimester)
54
Breast: what are the axillary node levels (1-3, and one more category)?
1 - lateral to pec minor; 2 - beneath pec minor; 3 - medial to pec minor; Rotter's Nodes - between pec major and pec minor
55
Breast: what do you do if you can't find radiotracer dye in SNLB?
ALND
56
Breast: what patient would get only mastectomy/BCT + tamoxifen for 5 years (4 characteristics)?
(-) SLN old ER+ tumor <2 cm
57
Breast: what patient would get mastectomy/BCT + tamoxifen for 5 years plus chemo (4 characteristics)?
(-) SLN, young, ER+, and tumor >1cm
58
Liver: in what population should giant liver hemangioma be resected, how can it present in this population (name of syndrome and its 2 problems, other possible problem)?
pediatric population -- kasabach-merit syndrome = hepatic sequestration and thrombocytopenia, also can present with AV shunting and heart failure
59
Colorectal: when is transanal excision OK (T stage, circumference, location, 2 criteria if invasive)?
stage - polyp or T1 circumference - <40% location - within 8-10cm of anal verge if invasive must be: 1) no lymphovascular invasion; 2) not poorly differentiated
60
Colorectal: coloncyte fuel, and derived from where?
butyric acid
61
GIST Treatment
R0 resection
62
Indications for adjuvant Gleeve
1. Ruptured GIST 2. >10 cm 3. Mitotic rate > 10/50 4. Tumor size >5cm & 5 mitosis/HPF
63
Nejoadjuvant therapy for GIST
Duodenal GIST Rectal GIST GEJ GIST
64
Colon Ca Tx
Stage I: Resection Stage II (T1-3, N0): Resection Stage II (T3, <12 nodes in specimen, poorly differentiated, lymphovascular invasion): Resection -> Adjuvant XT
65
Rectal CA Tx
CIS, T1: TEM (up to 15 cm) T2-3, N1-2: Neoadjuvant XRT
66
Rectal Ca < 5cm from dentate line
LAR with total mesorectal excision
67
Anal Ca Tx
AIN: Resection/Ablation T1, N0 (welll differentiated): Resection, Inadequate margins- Observe vs XRT Any T, N0, N+
68
X (chi squared)
Categorical >2 groups
69
Cox proportional hazards regression
Variables affecting survival
70
Paired t test
two groups: Before & After
71
Mann Whitney (Wilcoxon)
Two independent groups with ranks
72
EVAR Indications
External iliac: 7-16 mm Length of aorta: >15 mm Diameter of aneurysm: <26 mm
73
Zenker Diverticulum
< 3 cm: Open myotomy with diverticulopexy
74
Stitch Trial
5 mm from incision 5 mm vertcical distance No muscle 2-0 PDS, 31 mm needle
75
Papillary cystadenoma lymphomatosum (Warthin tumor)
Bilateral parotid masses Bilateral superficial parotidectomy
76